沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
沃森生物(300142) 利润表
单位:万元
报表日期2023-06-302023-03-312022-12-312022-09-302022-06-30
一、营业总收入216,767.1383,326.74508,644.52370,625.82234,804.37
营业收入216,767.1383,326.74508,644.52370,625.82234,804.37
二、营业总成本152,614.4466,153.95380,622.33274,946.81169,178.36
营业成本27,256.6712,484.7160,946.8843,439.3829,283.07
营业税金及附加1,971.251,161.883,325.102,509.811,311.34
销售费用78,304.6530,503.44202,216.99148,073.3690,349.81
管理费用12,089.545,823.3427,142.0018,568.4911,387.49
财务费用-3,526.25-1,710.24-6,298.09-5,377.99-3,184.07
研发费用36,518.5917,890.8293,289.4567,733.7640,030.72
资产减值损失----------
公允价值变动收益-1,765.29-119.29-19,933.49-21,263.74-7,172.66
投资收益632.84-26.771,179.69483.53-54.26
其中:对联营企业和合营企业的投资收益-40.40-21.57-107.39-67.10-54.26
汇兑收益----------
三、营业利润63,205.5521,447.86109,943.9982,907.2361,616.47
加:营业外收入91.324.8813.006.176.80
减:营业外支出494.49379.552,910.472,333.261,653.63
其中:非流动资产处置损失----------
四、利润总额62,802.3821,073.19107,046.5280,580.1359,969.64
减:所得税费用6,547.461,242.7913,223.8811,709.739,770.17
五、净利润56,254.9119,830.4093,822.6468,870.4150,199.46
归属于母公司所有者的净利润45,523.9817,199.0972,865.2053,139.3342,100.92
少数股东损益10,730.932,631.3120,957.4315,731.078,098.54
六、每股收益
基本每股收益(元/股)0.28440.10740.45460.33770.2629
稀释每股收益(元/股)0.28440.10740.45440.33740.2624
七、其他综合收益----85.00----
八、综合收益总额56,254.9119,830.4093,907.6468,870.4150,199.46
归属于母公司所有者的综合收益总额45,523.9817,199.0972,950.2053,139.3342,100.92
归属于少数股东的综合收益总额10,730.932,631.3120,957.4315,731.078,098.54
下载全部历史数据到excel中 返回页顶